Ligand Binding Analysis for Human α5β1 Integrin: Strategies for Designing New α5β1 Integrin Antagonists
- 1 June 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 48 (13), 4204-4207
- https://doi.org/10.1021/jm040224i
Abstract
We report a three-dimensional model of the α5β1 integrin headgroup bound to the most potent and selective ligand (SJ749) known to date. The model was built using the comparative protein modeling method, and it is consistent with experimental data. From this study, we identified two potentially important regions in the α5β1 receptor that are peculiar to this integrin and might be worth considering for drug targeting.Keywords
This publication has 28 references indexed in Scilit:
- IntegrinsCell, 2002
- Identification of the Principal Binding Site for RGD-Containing Ligands in the αVβ3 Integrin: A Photoaffinity Cross-Linking StudyBiochemistry, 2002
- Resolution of Lung Inflammation by CD44Science, 2002
- Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrinsNature Medicine, 2002
- N-Methylated Cyclic RGD Peptides as Highly Active and Selective αVβ3Integrin AntagonistsJournal of Medicinal Chemistry, 1999
- Stereoisomeric Peptide Libraries and Peptidomimetics for Designing Selective Inhibitors of the αvβ3 Integrin for a New Cancer TherapyAngewandte Chemie International Edition in English, 1997
- CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceNucleic Acids Research, 1994
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994
- Selective Inhibition of Trypanosomal Triosephosphate Isomerase by a ThiopeptideAngewandte Chemie International Edition in English, 1992
- Strategic approaches to drug design. I. An integrated software framework for molecular modellingJournal of Computer-Aided Molecular Design, 1987